Info: Zenodo’s user support line is staffed on regular business days between Dec 23 and Jan 5. Response times may be slightly longer than normal.

Published April 28, 2023 | Version v1
Journal article Open

Comparative Analysis of the Structure and Function of the Pancreas in Patients with a Combination of Chronic Pancreatitis and Metabolic Syndrome

Creators

  • 1. I. Horbachevsky Ternopil National Medical University, Ukraine

Description

Metabolic syndrome (MS) is the most urgent problem of modern medicine, which is associated with an unhealthy lifestyle. This is a complex metabolic disorder based on insulin resistance and compensatory hyperinsulinemia. MS is a risk factor for the development of a significant number of various diseases.

The objective: to determine the structural and functional state of the liver and pancreatic gland (PG) in patients with chronic pancreatitis (CP) depending on the presence of MS.

Materials and methods. 137 patients with CP of biliary genesis (CBP) were included in the study. Patients were divided into two groups: the 1st group – 22 persons with isolated CBP, the 2nd group – 115 patients with CBP+MS. The control group included 20 practically healthy subjects. The age of the study participants ranged from 30 to 71 years.

The presence of MS was determined, the state and structure of the PG and liver were examined.

Results. A statistically significant higher content of HbA1c was determined in patients with CBP and MS compared to the group of patients with only CBP (6.10±0.14% vs. 5.47±0.15%). A significantly higher blood glucose level was found in the patients with CBP+MS (5.99±0.29 mmol/l vs. 5.31±0.12 mmol/l) compared to patients with CBP. A significantly higher level of the HOMA index was also determined in the group of patients with CBP+MS compared to the CBP group (2.60±0.10 vs.1.84±0.09).

A higher level of liver stiffness was found in patients with CBP compared to the control group.

The indicator of fecal α-elastase in patients with CBP+MS was 114.52±2.79 mcg/g, which was significantly lower than that in the group of patients with CBP without MS (158.60±5.55 mcg/g).

Conclusions. In the presence of MS in patients with chronic biliary pancreatitis, more significant structural disorders in the liver and pancreas were established in the direction of increased density according to shear wave elastometry. The results of the study demonstrated the aggravating effect of concomitant MS on the structural state of the liver and on the structural and functional state of the pancreas in patients with chronic biliary pancreatitis.

Files

Comparative_Analysis_of_the_Structure_and_Function_of_the_Pancreas_in_Patients_with_a_Combination_of_Chronic_Pancreatitis_and_Metabolic_Syndrome.pdf

Files (1.6 MB)

Additional details

References

  • Alkully T, Darr U, Renno A, Khan Z, Oraibi O, Ruzieh M, et al. Su1327 Endoscopic Ultrasound Findings of Fatty Pancreas; Incidence, Etiology, and Clinical Implication. Gastrointestinal Endoscopy. 2016;83(5):AB353 doi: 10.1016/j.gie.2016.03.900.
  • Babinets LS, Melnyk NA. Comparative analysis of life quality parameters of patients with a combination of stable coronary artery disease and metabolic syndrome. Roman J Diabetes Nutr Metabol Dis. 2022;29(2):167–72. doi: 10.46389/rjd-2022-1088.
  • Babinets LS, Kytsai KY, Kotsaba YY, Halabitska IM, Melnyk NA, Semenova IV, et al. Improvement of the complex medical treatment for the patients wіth chronic biliary pancreatitis. Wiad Lek. 2017;70(2):213–6.
  • Bi Y, Wang J-L, Li M-L. The association between pancreas steatosis and metabolic syndrome: A systematic review and meta-analysis. Diabetes Metabol Res Rev. 2019;35(5):e3142. doi: 10.1002/dmrr.3142.
  • Chan TT, Tse YK, Lui RN, Wong GL, Chim AM, Kong AP, et al. Fatty Pancreas Is Independently Associated With Subsequent Diabetes Mellitus Development: a 10-year Prospective Cohort Study. Clin Gastroenterol Hepatol. 2022;20(9):2014–2022.e4. doi: 10.1016/j.cgh.2021.09.027.
  • Danielsson O, Nissinen MJ, Jula A, Salomaa V, Männistö S, Lundqvist A, et al. Waist and hip circumference are independently associated with the risk of liver disease in population-based studies. Liver Int. 2021;41(12):2903–13. doi: 10.1111/liv.15053.
  • Després JP, Lemieux I. Abdominal obesity and metabolic syndrome. Nature. 2006;444(7121):881–7. doi: 10.1016/j.atherosclerosis.2012.05.016.
  • DiMagno EP, DiMagno MJ. Chronic Pancreatitis: Landmark Papers, Management Decisions, and Future. Pancreas. 2016;45(5):641–50. doi: 10.1097/MPA.0000000000000599.
  • DiMagno MJ, DiMagno EP. Chronic pancreatitis. Current Opin Gastroenterol. 2012;28(5):523–31. doi: 10.1097/01.mog.0000175543.42582.55.
  • Dominguez-Muñoz JE. Management of pancreatic exocrine insufficiency. Current Opin Gastroenterol. 2019;35(5):455–9. doi: 10.1097/MOG.0000000000000562.
  • Domínguez-Muñoz JE, Phillips M. Nutritional therapy in chronic pancreatitis. Gastroenterology Clinics of North America. 2018;47(1):95–106. doi: 10.1016/j.gtc.2017.09.004.
  • Ferfetska KV, Fediv OI. The role of the metabolic syndrome in the development of chronic pancreatitis (literature review). Bukovyna Medical Herald. 2013;17(2):174–8.
  • Girman CJ, Kou TD, Cai B, Alexander CM, O'Neill EA, Williams-Herman DE, et al. Patients with type 2 diabetes mellitus have higher risk for acute pancreatitis compared with those without diabetes. Diabetes Obes Metab. 2010;12(9):766–71. doi: 10.1111/j.1463-1326.2010.01231.x.
  • Habtezion A. Inflammation in acute and chronic pancreatitis. Current Opin Gastroenterol. 2015;31(5):395–9. doi: 10.1097/MOG.0000000000000195.
  • Khrystych TN, Hontsaryuk DA. Chronic pancreatitis in comorbid disorder with metabolic syndrome. Bulletin club Pancreatol. 2019;2(43):15–9.
  • Koh JC, Loo WM, Goh KL, Sugano K, Chan WK, Chiu WY, et al. Asian consensus on the relationship between obesity and gastrointestinal and liver diseases. J Gastroenterol Hepatol. 2016;31(8):1405–13. doi: 10.1111/jgh.13385.
  • Kromrey ML, Friedrich N, Hoffmann RT, Bülow R, Völzke H, Weiss FU, et al. Pancreatic Steatosis Is Associated With Impaired Exocrine Pancreatic Function. Invest Radiol. 2019;54(7):403–8. doi: 10.1097/RLI.0000000000000554.
  • Löhr JM, Dominguez-Munoz E, Rosendahl J, Besselink M, Mayerle J, Lerch MM, et al. United European Gastroenterology evidence-based guidelines for the diagnosis and therapy of chronic pancreatitis (HaPanEU). United European Gastroenterol J. 2017;5(2):153–99. doi: 10.1177/2050640616684695.
  • Löhr JM, Oliver MR, Frulloni L. Synopsis of recent guidelines on pancreatic exocrine insufficiency. United European Gastroenterol J. 2013;1(2):79–83. doi: 10.1177/2050640613476500.
  • Majumder S, Philip NA, Takahashi N, Levy MJ, Singh VP, Chari ST. Fatty Pancreas: Should We Be Concerned? Pancreas. 2017;46(10):1251–8. doi: 10.1097/MPA.0000000000000941.
  • Melitas C, Meiselman M. Metabolic Pancreatitis: Pancreatic Steatosis, Hypertriglyceridemia, and Associated Chronic Pancreatitis in 3 Patients with Metabolic Syndrome. Case Rep Gastroenterol. 2018;12(2):331–6. doi: 10.1159/000490042.
  • Redkva OV, Babinets LS, Нalabitska IM. Evaluation of parameters of actual typical pathogenetic syndromes in comorbidity of type 2 diabetes mellitus and chronic pancreatitis. Wiad Lek. 2021;7(10):2557–9.
  • Rodrigues-Pinto E, Caldeira A, Soares JB, Antunes T, Carvalho JR, Costa-Maia J, et al. Clube Portugues do Pancreas Recommendations for Chronic Pancreatitis: Etiology, Natural History, and Diagnosis (Part I). GE Port J Gastroenterol. 2019;26(5):346–55. doi: 10.1159/000497388.
  • Scherer J, Singh VP, Pitchumoni CS, Yadav D. Issues in hypertriglyceridemic pancreatitis: an update. J Clin Gastroenterol. 2014;48(3):195–203. doi: 10.1097/01.mcg.0000436438.60145.5a.
  • Uygun A, Kadayifci A, Demirci H, Saglam M, Sakin YS, Ozturk K, et al. The effect of fatty pancreas on serum glucose parameters in patients with nonalcoholic steatohepatitis. Eur J Intern Med. 2015;26(1):37–41. doi: 10.1016/j.ejim.2014.11.007.
  • Yu Q, Pang B, Liu R, Rao W, Zhang S, Yu Y. Appropriate Body Mass Index and Waist-hip Ratio Cutoff Points for Overweight and Obesity in Adults of Northeast China. Iran J Public Health. 2017;46(8):1038–45.